In January 2023, FDA announced that it would like to work with Congress to craft a legislative approach to the regulation of CBD products.

In January 2023, FDA announced that it would like to work with Congress to craft a legislative approach to the regulation of CBD products.
This report was ordered by the Oklahoma Medical Marijuana Authority (OMMA) to examine the supply chain and demand of the medical cannabis market…
The Cannabis Legalization and Public Health Outcomes: Part I study is one of the largest studies to date on cannabis legalization and cannabis use. The study analyzes and compares survey data from approximately 5,000 U.S. residents across 25 U.S. states with varying...
Introduction Cannabis Policy Simulation Lab: Solving Cannabis Policy Questions with Data Science The Cannabis Policy Simulation Lab integrates a joint database that includes the quarterly Regulatory Determinants of Cannabis Outcomes Survey (RDCOS) outcomes and state...
Introduction Cannabis Policy Simulation Lab: Solving Cannabis Policy Questions with Data Science The Cannabis Policy Simulation Lab is a joint database between CPPC's quarterly Regulatory Determinants of Cannabis Outcomes Survey (RDCOS) outcomes and state cannabis...